Sanford C. Bernstein set a CHF 262 target price on Roche (VTX:ROG) in a report issued on Friday morning. The firm currently has a buy rating on the healthcare company’s stock.
Several other brokerages have also recently commented on ROG. Deutsche Bank set a CHF 254 target price on Roche and gave the stock a neutral rating in a report on Thursday, November 23rd. Liberum Capital set a CHF 279 target price on Roche and gave the stock a buy rating in a report on Wednesday, November 22nd. Baader Bank set a CHF 256 target price on Roche and gave the stock a buy rating in a report on Tuesday, November 21st. HSBC set a CHF 205 target price on Roche and gave the stock a sell rating in a report on Tuesday, November 21st. Finally, Berenberg Bank set a CHF 260 target price on Roche and gave the stock a neutral rating in a report on Monday, November 20th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the company. The stock has a consensus rating of Hold and an average target price of CHF 260.56.
Shares of Roche (ROG) opened at CHF 247 on Friday. Roche has a 1 year low of CHF 218.30 and a 1 year high of CHF 273.
TRADEMARK VIOLATION WARNING: This report was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/05/sanford-c-bernstein-analysts-give-roche-rog-a-chf-262-price-target.html.
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.